Amanda Michelle Pebenito, MD
Gastroenterology
Accepting new patients
Sees patients age 18 and up
Penn Gastroenterology Perelman
Headshot of Amanda Michelle Pebenito, MD
Penn Medicine Provider

About me

  • Instructor A of Medicine (Gastroenterology)
  • NRSA Postdoctoral Fellow of Medicine (Gastroenterology)

Education and training

  • Medical School: New York University School of Medicine
  • Residency: Mass General Brigham Healthcare Center - Chestnut Hill
  • Fellowship: University of Pennsylvania Health System

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Pebenito is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Hewlett, K.*, PeBenito, A.*, Hecht AL.*, Tiffany C., Tanes C., Glover, R.C., Fawad, JA., Friedman, ES., Reynolds, JC., Bittinger, K., Lewis, JD., Wu, GD., Ahuja, NK., Zackular, JP. Dietary fiber modulates the window of susceptibility to Clostridioides difficile infection. , Gastroenterology, 169(5)): 2025,970-982


PeBenito, A., Scoggins, T.R., Prentice, B., Zackular, J. Metabolic markers of Clostridioides difficile infection in the setting of inflammatory colitis , Digestive Disease Week Washington, D.C.: 2024


PeBenito, A., Scoggins, T.R., Prentice, B., Zackular, J. Metabolic markers of Clostridioides difficile infection in the setting of inflammatory colitis , Keystone Symposia: Mechanisms of Microbiota-Immune Interactions-Towards the Next Decade. Snowbird, UT: 2023


Vannier, AGL*., PeBenito, A.*, Fomin, V., Chung, R.T., Schaefer, E., Goodman, R.P., Luther, J. An exploratory analysis of the competing effects of alcohol use and advanced hepatic fibrosis on serum HDL , Clin Exp Med : 2022,103-110


Vannier, AGL, Wardwell, B., Fomin, V., PeBenito, A., Wolczynski, N., Piaker, S., Kedrin, D., Chung, R.T., Schaefer, E., Goodman, R., Patel, S.J., Luther, J. Serum HMGB1 Associates with Liver Disease and Predicts Readmission and Mortality in Patients with Alcohol Use Disorder. , Alcohol , 95: 2021,37-43


PeBenito, A., Sridharan, V., Lumish, M., Wang, T., Darnell, E., Weniger, M., Fernández-Del Castillo, C., Casey, B., Hernandez-Barco, Y.G., Krishnan, K. Proton pump inhibitor (PPI) use and rates of cholangitis in patients with pancreatic cancer , Digestive Disease Week Chicago, IL: 2020


PeBenito, A., Vannier, A., Goodman, R., Schaefer, E., Luther, J. The competing effects of alcohol use and liver disease on serum HDL in patients with alcohol-related liver disease , The Liver Meeting, American Association for the Study of Liver Disease: 2020


PeBenito, A., Liu, M., Nazzal, L. & Blaser, M. J. Development of a Humanized Murine Model for the Study of Oxalobacter formigenes Intestinal Colonization , The Journal of Infectious Diseases, 220(11): 2019,1848-1858


PeBenito, A., Nazzal, L., Wang, C., Li, H., Jay, M., Noya-Alarcon, O., Contreras, M., Lander, O., Leach, J., Dominguez-Bello, M.G., Blaser, M.J. Comparative prevalence of Oxalobacter formigenes in three human populations. , Scientific Reports, 9(1): 2019,574


PeBenito, A., Liu, M., Nazzal, L., & Blaser, M.J. Development of a humanized murine model for the study of Oxalobacter formigenes intestinal colonization , American Society of Nephrology: International Kidney Week; New Orleans, LA: 2017